Talk:Dextrorphan: Difference between revisions
>ExistingEntity m added a space |
>LockPicker standardizing |
||
(8 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
{{decree|type=notice|message=This article is in the 'Talk' namespace because it is an unfinished draft. This section is used to host drafts for unpublished articles as well as discussions for published ones. If you'd like to use this area to discuss this draft, please do so in the 'Discussion' section at the very bottom of the page. This notice will be removed once this draft has been approved for publication by an administrator.}} | |||
{{headerpanel|{{approval}}}} | |||
{{headerpanel|{{ | {{SummarySheet}} | ||
{{SubstanceBox/DXO}} | |||
'''Dextrorphan''' (also known as '''DXO''') is a [[dissociative]] drug of the [[morphinan]] class. It's the main active metabolite of [[dextromethorphan]] ('''DXM'''). It appears as a colorless powder.<ref> | '''Dextrorphan''' (also known as '''DXO''') is a [[dissociative]] drug of the [[morphinan]] class. It's the main active metabolite of [[dextromethorphan]] ('''DXM'''). It appears as a colorless powder.<ref> | ||
"Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student." Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student. Erowid.org, 15 Sept. 2001. Web. 15 Apr. 2015 | "Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student." Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student. Erowid.org, 15 Sept. 2001. Web. 15 Apr. 2015 | https://www.erowid.org/chemicals/dxm/dxm_info3.shtml</ref> | ||
==Chemistry== | ==Chemistry== | ||
Dextrorphan is a dextrorotatory molecule of the morphinan class. It contains a phenanthrene core structure with one aromatic ring (benzene) bound to two saturated rings (cyclohexane). [[Dextromethorphan]] is metabolized in the body by o-demethylation through the CYP2D6 enzyme to form Dextrorphan.<ref>Cytochrome P450-dependent metabolism of dextromethorphan: fetal and adult studies. | Dextrorphan is a dextrorotatory molecule of the morphinan class. It contains a phenanthrene core structure with one aromatic ring (benzene) bound to two saturated rings (cyclohexane). [[Dextromethorphan]] is metabolized in the body by o-demethylation through the CYP2D6 enzyme to form Dextrorphan.<ref>Cytochrome P450-dependent metabolism of dextromethorphan: fetal and adult studies. | https://www.ncbi.nlm.nih.gov/pubmed/1306804</ref> | ||
==Pharmacology== | ==Pharmacology== | ||
The pharmacology of dextrorphan is similar to that of dextromethorphan (DXM). However, dextrorphan is much more potent as an [[NMDA receptor antagonist]] as well as essentially inactive as a [[serotonin]] [[reuptake inhibitor]].<ref>Psychotropic Effects of Dextromethorphan Are Altered by the CYP2D6 Polymorphism: A Pilot Study | The pharmacology of dextrorphan is similar to that of dextromethorphan (DXM). However, dextrorphan is much more potent as an [[NMDA receptor antagonist]] as well as essentially inactive as a [[serotonin]] [[reuptake inhibitor]].<ref>Psychotropic Effects of Dextromethorphan Are Altered by the CYP2D6 Polymorphism: A Pilot Study | http://journals.lww.com/psychopharmacology/pages/articleviewer.aspx?year=1998&issue=08000&article=00014&type=abstract</ref> DXO is an active chemical and contributes to the [[DXM#Subjective effects|subjective effects]] experienced when active doses of DXM are consumed.<ref>Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders - 3. Pharmacodynamics (January 2016) | https://www.researchgate.net/publication/292212463_Dextromethorphan_An_update_on_its_utility_for_neurological_and_neuropsychiatric_disorders</ref> | ||
===Binding affinities (K<sub>i</sub>)=== | ===Binding affinities (K<sub>i</sub>)=== | ||
Line 23: | Line 23: | ||
One user reported excessive itchiness accompanied by a "peaceful yet emotionless state" after 340mg of the substance was consumed.<ref> | One user reported excessive itchiness accompanied by a "peaceful yet emotionless state" after 340mg of the substance was consumed.<ref> | ||
"Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student." Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student. Erowid.org, 15 Sept. 2001. Web. 15 Apr. 2015 | "Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student." Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student. Erowid.org, 15 Sept. 2001. Web. 15 Apr. 2015 | https://www.erowid.org/chemicals/dxm/dxm_info3.shtml</ref> | ||
{{effects/base | |||
|{{effects/physical| | |||
*'''[[Effect::Appetite suppression]]''' | *'''[[Effect::Appetite suppression]]''' | ||
*'''[[Effect::Changes in felt bodily form]]''' | *'''[[Effect::Changes in felt bodily form]]''' | ||
Line 37: | Line 38: | ||
*'''[[Effect::Tactile disconnection]]''' | *'''[[Effect::Tactile disconnection]]''' | ||
*'''[[Effect::Tactile suppression]]''' | *'''[[Effect::Tactile suppression]]''' | ||
}} | |||
|{{effects/cognitive| | |||
*'''[[Effect::Amnesia]]''' | *'''[[Effect::Amnesia]]''' | ||
*'''[[Effect::Conceptual thinking]]''' | *'''[[Effect::Conceptual thinking]]''' | ||
Line 57: | Line 58: | ||
*'''[[Effect::Time distortion]]''' | *'''[[Effect::Time distortion]]''' | ||
*'''[[Effect::Unity and interconnectedness]]''' | *'''[[Effect::Unity and interconnectedness]]''' | ||
}} | |||
}} | |||
===Experience reports=== | |||
There are currently {{#ask:[[Category:DXO]][[Category:Experience]] | format=count}} experience reports which describe the effects of this substance in our [[experience index]]. | |||
{{#ask: [[Category:DXO]][[Category:Experience]]|format=ul|Columns=1}} | |||
Additional experience reports can be found here: | |||
*[https://www.erowid.org/experiences/subs/exp_DXO.shtml Erowid Experience Vaults: DXO] | |||
==Toxicity and harm potential== | |||
{{toxicity}} | |||
It is strongly recommended that one use [[responsible use|harm reduction practices]] when using this substance. | |||
===Lethal dosage=== | |||
===Tolerance and addiction potential=== | |||
===Dangerous interactions=== | |||
{{DangerousInteractions}} | |||
{{DangerousInteractions/Intro}} | |||
{{DangerousInteractions/Dissociatives}} | |||
==Legal issues== | ==Legal issues== | ||
{{legalStub}} | {{legalStub}} | ||
* '''Germany | * '''Germany''': Dextrorphan is uncontrolled.{{citation needed|date=November 2020}} | ||
* '''Poland | * '''Poland''': Dextrorphan is unscheduled.<ref>List of scheduled substances in Poland. | http://www2.mz.gov.pl/wwwfiles/ma_struktura/docs/zal2_uopnarkomanii_29072005.pdf</ref> | ||
* '''United States''': Dextrorphan is unscheduled since October 1, 1976.<ref>DEA: "Lists of: Scheduling Actions Controlled Substances Regulated Chemicals"</ref> | |||
* '''United States | |||
==See also== | ==See also== | ||
Line 72: | Line 89: | ||
*[[Morphinan]] | *[[Morphinan]] | ||
*[[MXE]] | *[[MXE]] | ||
==External links== | |||
*[[wikipedia:Dextrorphan|Dextrorphan (Wikipedia)]] | |||
==References== | ==References== | ||
<references /> | <references /> | ||
[[Category:Psychoactive substance]] | [[Category:Psychoactive substance]] | ||
[[Category:Morphinan]] | [[Category:Morphinan]] | ||
[[Category:Dissociative]] | [[Category:Dissociative]] | ||
[[Category:Approval]] | |||
[[Category:Proofread]] |